新聞/Reuters/UCB Announces Positive Phase 3 Studies For Bimekizumab In Hidrade…UCB Announces Positive Phase 3 Studies For Bimekizumab In Hidradenitis Suppurativa2022年12月9日13:54 [UTC]UCBUCB SA UCB:UCB ANNOUNCES POSITIVE PHASE 3 STUDIES FOR BIMEKIZUMAB IN HIDRADENITIS SUPPURATIVA